Standard
265th ENMC International Workshop : Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands. / Monforte, Mauro; Attarian, Shahram; Vissing, John; Diaz-Manera, Jordi; Tasca, Giorgio; 265th ENMC workshop participants.
In:
Neuromuscular Disorders, Vol. 33, No. 1, 2023, p. 65-75.
Research output: Contribution to journal › Journal article › Communication
Harvard
Monforte, M, Attarian, S
, Vissing, J, Diaz-Manera, J, Tasca, G & 265th ENMC workshop participants 2023, '
265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands',
Neuromuscular Disorders, vol. 33, no. 1, pp. 65-75.
https://doi.org/10.1016/j.nmd.2022.10.005APA
Monforte, M., Attarian, S.
, Vissing, J., Diaz-Manera, J., Tasca, G., & 265th ENMC workshop participants (2023).
265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands.
Neuromuscular Disorders,
33(1), 65-75.
https://doi.org/10.1016/j.nmd.2022.10.005Vancouver
Monforte M, Attarian S
, Vissing J, Diaz-Manera J, Tasca G, 265th ENMC workshop participants.
265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands.
Neuromuscular Disorders. 2023;33(1):65-75.
https://doi.org/10.1016/j.nmd.2022.10.005Author
Monforte, Mauro ; Attarian, Shahram ; Vissing, John ; Diaz-Manera, Jordi ; Tasca, Giorgio ; 265th ENMC workshop participants. / 265th ENMC International Workshop : Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands. In: Neuromuscular Disorders. 2023 ; Vol. 33, No. 1. pp. 65-75.
Bibtex
@article{4b5cf68376064ae38fd306c5ad10c7d6,
title = "265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands",
keywords = "Biomarkers, Facioscapulohumeral Muscular Dystrophy, FSHD, Muscle imaging, Muscle MRI",
author = "Mauro Monforte and Shahram Attarian and John Vissing and Jordi Diaz-Manera and Giorgio Tasca and {265th ENMC workshop participants}",
note = "Funding Information: The workshop was made possible thanks to the financial support of the European Neuromuscular center (ENMC) and ENMC main sponsors: Association Fran{\c c}aise contre les Myopathies (France), Deutsche Gesellschaft f{\"u}r Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Fonds (The Netherlands), Schweizerische Stiftung f{\"u}r die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands), and Associated Partners: Finnish Neuromuscular Association (Finland), {\"O}sterreichische Muskelforschung (Austria), SMA Europe and World Duchenne organisation. In addition, we would like to thank the members of the ENMC Company Forum: Sanofi, Roche, Lupin Neuroscience, Amicus Therapeutics, Ionis Pharmaceuticals, Biogen, Novartis, PerkinElmer and Astellas. Funding Information: Data presented by Anna Pichiecchio were generated in a project funded by Italian Ministry of Health (RF-2016–02362914). Funding Information: This workshop was supported by the European Neuromuscular center (ENMC). Funding Information: - Hermien Kan receives research support from Philips Healhtcare and trial support from ImagingDMD. No personal fees are received, all revenues go to the LUMC;",
year = "2023",
doi = "10.1016/j.nmd.2022.10.005",
language = "English",
volume = "33",
pages = "65--75",
journal = "Journal of Neuromuscular Diseases",
issn = "0960-8966",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - 265th ENMC International Workshop
T2 - Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands
AU - Monforte, Mauro
AU - Attarian, Shahram
AU - Vissing, John
AU - Diaz-Manera, Jordi
AU - Tasca, Giorgio
AU - 265th ENMC workshop participants
N1 - Funding Information:
The workshop was made possible thanks to the financial support of the European Neuromuscular center (ENMC) and ENMC main sponsors: Association Française contre les Myopathies (France), Deutsche Gesellschaft für Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Fonds (The Netherlands), Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands), and Associated Partners: Finnish Neuromuscular Association (Finland), Österreichische Muskelforschung (Austria), SMA Europe and World Duchenne organisation. In addition, we would like to thank the members of the ENMC Company Forum: Sanofi, Roche, Lupin Neuroscience, Amicus Therapeutics, Ionis Pharmaceuticals, Biogen, Novartis, PerkinElmer and Astellas.
Funding Information:
Data presented by Anna Pichiecchio were generated in a project funded by Italian Ministry of Health (RF-2016–02362914).
Funding Information:
This workshop was supported by the European Neuromuscular center (ENMC).
Funding Information:
- Hermien Kan receives research support from Philips Healhtcare and trial support from ImagingDMD. No personal fees are received, all revenues go to the LUMC;
PY - 2023
Y1 - 2023
KW - Biomarkers
KW - Facioscapulohumeral Muscular Dystrophy
KW - FSHD
KW - Muscle imaging
KW - Muscle MRI
U2 - 10.1016/j.nmd.2022.10.005
DO - 10.1016/j.nmd.2022.10.005
M3 - Journal article
C2 - 36369218
AN - SCOPUS:85141458374
VL - 33
SP - 65
EP - 75
JO - Journal of Neuromuscular Diseases
JF - Journal of Neuromuscular Diseases
SN - 0960-8966
IS - 1
ER -
